Kathleen S. Wright Associates’s Vanguard Total International Stock ETF VXUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.98M Buy
27,018
+3,443
+15% +$244K 0.74% 33
2025
Q2
$1.63M Buy
23,575
+3,981
+20% +$258K 0.64% 35
2025
Q1
$1.22M Buy
19,594
+1,273
+7% +$78.6K 0.5% 38
2024
Q4
$1.08M Buy
18,321
+542
+3% +$33.6K 0.45% 44
2024
Q3
$1.15M Buy
17,779
+1,052
+6% +$65.1K 0.47% 44
2024
Q2
$1.01M Buy
16,727
+401
+2% +$24.2K 0.46% 45
2024
Q1
$984K Buy
16,326
+184
+1% +$10.7K 0.46% 44
2023
Q4
$936K Sell
16,142
-1,460
-8% -$79.7K 0.48% 46
2023
Q3
$942K Sell
17,602
-3,636
-17% -$203K 0.53% 46
2023
Q2
$1.19M Sell
21,238
-57
-0.3% -$3.19K 0.76% 36
2023
Q1
$1.18M Buy
21,295
+4,135
+24% +$226K 0.77% 36
2022
Q4
$888K Buy
17,160
+292
+2% +$14.6K 0.6% 42
2022
Q3
$772K Buy
+16,868
New +$863K 0.63% 39

Other funds holding VXUS

Kathleen S. Wright Associates's VXUS Position: Q3 2025 in Review

Kathleen S. Wright Associates increased its Vanguard Total International Stock ETF (VXUS) stake by 15% in Q3 2025, buying an estimated $244K and bringing the position to 27,018 shares worth $1.98M. The position accounts for 0.74% of the portfolio, ranked #33.

Kathleen S. Wright Associates first reported a position in VXUS in Q3 2022 and has held it in 13 quarters since. 1,462 funds tracked by Wall St. Rank hold VXUS as of Q3 2025.

  • Kathleen S. Wright Associates held 27,018 shares of Vanguard Total International Stock ETF worth $1.98M as of Q3 2025.
  • Kathleen S. Wright Associates bought 3,443 Vanguard Total International Stock ETF shares in Q3 2025, an estimated $244K.
  • Vanguard Total International Stock ETF made up 0.74% of Kathleen S. Wright Associates's portfolio in Q3 2025, its #33 holding.
  • Kathleen S. Wright Associates first reported a position in Vanguard Total International Stock ETF in Q3 2022 and has held it in 13 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Vanguard Total International Stock ETF as of Q3 2025.

Based on Kathleen S. Wright Associates's 13F filing for Q3 2025, filed 10 Oct 2025.